Document:

Separation Letter Agreement and General Release

 Exhibit 10.50 

 
 

 
 October 21, 2011 
 Steven M. Lutz 
 123 Trellingwood 
 Morrisville, NC 27560 
 Re: Separation Letter Agreement and General Release 

Dear Steve: 
 As we have
discussed, your employment with Cornerstone Therapeutics Inc. (the “Company”) and your Amended and Restated Executive Employment Agreement with the Company dated May 6, 2009 (the “Employment Agreement”) are being terminated
by the Company “without cause.” This Separation Letter Agreement and General Release (this “Agreement”) sets forth the terms of the separation package that you will receive if you enter into this Agreement. You were provided
this Agreement by hand delivery on September 29, 2011 and advised that you had twenty-one (21) days from your receipt of the Agreement to consider it. You and the Company engaged in certain negotiations following your receipt of the
Agreement and agreed to extend the review period for an additional twenty-one (21) days. Once you have signed this Agreement, you will have seven (7) days to revoke your acceptance as set forth in Paragraphs Nos. 8 and 18 below. Please
note that the earliest you can accept this Agreement is the Termination Date (as defined below). Please read this Agreement carefully and review it with your attorney. If you are willing to agree to its terms, please sign and date in the
space provided on the signature page and return it to the Director, Human Resources of the Company at the address set forth in Paragraph No. 20.
 1. Whether or not you choose to timely sign and return this Agreement, your employment with the Company will end as of September 30, 2011 (the “Termination Date”), provided that you
satisfactorily perform your job and comply with Company policies and practices as determined in good faith by the Company through the Termination Date. Whether or not you choose to sign this Agreement, you will be paid on or about the
Termination Date the following: 
  

	 	(a)	your unpaid current base salary through the Termination Date, less lawful deductions; and 

 

	 	(b)	your unused and accrued vacation as of the Termination Date.  

 2. After the Termination Date, except as provided below, you will not be entitled to receive
any benefits paid by, or participate in any benefit programs offered by the Company to its employees, including, but not limited to, the Company’s 401(k) plan, stock option plans, bonus plans, commission plans, sales incentive plans, retention
agreements, severance, expense reimbursements, life insurance or disability insurance programs, except as required by federal or state law or as otherwise described to you in writing in such plan or program documents. You will receive, under
separate cover, information concerning your right to continue your health insurance and dental insurance benefits after that date in accordance with COBRA. You must complete the COBRA enrollment documents within the required period in order to
continue this coverage. Under the terms of the Company’s stock option plans, and except as provided in paragraph 3 of Attachment A, you cease further vesting of stock options upon the Termination Date. 

3. In consideration for your timely signing of this Agreement, and the promises made herein, the Company agrees to provide you with the
monies and benefits set forth in Attachment A (Description of Severance Benefits) (attached hereto) provided that you do not revoke your acceptance of this Agreement pursuant to Paragraph No. 18 below. The distribution of all
severance payments and benefits provided in Attachment A shall be subject to the provisions of Attachment B (Payments Subject to Section 409A) (attached hereto).

4. You also understand and agree that you would not receive the monies and/or benefits specified in Paragraph No. 3 above, except
for your execution of this Agreement and the fulfillment of the promises contained herein. You acknowledge and agree that such payments shall be provided in lieu of any severance plan of the Company, any benefits or severance arrangements under
your Employment Agreement and any benefits under your employment offer letter. You acknowledge and agree that you are solely responsible for the following: 
  

	 	(a)	properly and timely electing to continue health and dental insurance coverage under COBRA; and 

 

	 	(b)	promptly notifying the Company if you become eligible for coverage under the group health plan of another employer prior to twelve (12) months after the
Termination Date. 

 5. In consideration of the payments to be made by the Company to you as set forth in
Paragraph No. 3 above and the promises contained in this Agreement, you hereby voluntarily and of your own free will agree to release, remise, forever discharge and hold harmless the Company, its past, present and future subsidiaries, corporate
affiliates, parent companies, and its and/or their past, present and future officers, directors, stockholders, trustees, successors and assigns, agents and employees (each in both their individual and corporate capacities)

 
(hereinafter, the “Releasees”) from any and all claims, charges, complaints, demands, actions, causes of action, suits, rights, debts, sums of money, costs, accounts, reckonings,
covenants, contracts, agreements, promises, doings, omissions, damages, executions, obligations, liabilities, and expenses (including attorneys’ fees and costs), of every kind and nature, whether known or unknown, that might be asserted arising
out of your employment by and separation from the Company, including, but not limited to, (1) the National Labor Relations Act, as amended; (2) Title VII of the Civil Rights Act of 1964, as amended; (3) Sections 1981 through 1988 of
Title 42 of the United States Code, as amended; (4) the Age Discrimination in Employment Act of 1967, as amended (“ADEA”); (5) the Older Workers Benefit Protection Act (“OWBPA”); (6) the Immigration Reform Control
Act, as amended; (7) the Employee Retirement Income Security Act of 1974, 29 U.S.C. § 1001, et seq., except for any claims for benefits vested, due and owing; (8) the Occupational Safety and Health Act, as amended;
(9) the Civil Rights Act of 1866, 29 U.S.C. § 1981, et seq; (10) the Rehabilitation Act of 1973, 29 U.S.C. § 701, et seq.; (11) the Americans With Disabilities Act of 1990, as amended; (12) the
Civil Rights Act of 1991; (13) the Workers Adjustment and Retraining Notification Act, as amended; (14) the Family and Medical Leave Act, as amended; (15) Section 806 of the Corporate and Criminal Fraud Accountability Act of 2002;
(16) Executive Order 11141; (17) the Fair Credit Reporting Act, 15 U.S.C. § 1681 et seq.; (18) any other federal or state law, regulation, or ordinance; (19) any public policy, contract, tort, or common law;
(20) all claims to any non-vested ownership interest in the Company, contractual or otherwise, including but not limited to claims to stock or stock options (except as set forth in Attachment A); and (21) any claim for costs, fees,
or other expenses including attorneys’ fees incurred in these matters. The release of claims set forth in this paragraph does not apply to claims for workers’ compensation benefits or unemployment benefits filed with the applicable
state agencies. You agree that neither this Agreement, nor the furnishing of consideration for this Agreement, shall be deemed or construed at any time for any purpose as an admission by the Company of any liability or unlawful conduct of any
kind.
 6. You will not sue the Releasees on any matters relating to your employment arising before the execution of this
Agreement, including, but not limited to, claims under the ADEA, or join as a party with others who may sue Releasees on any such claims. Provided, however, nothing in this Agreement prevents you from filing, cooperating with, or participating in
any proceeding before the EEOC or a State Fair Employment Practices Agency (except that you acknowledge that you may not be able to recover any monetary benefits in connection with any such claim, charge or proceeding), from challenging under the
OWBPA the enforceability of the waiver and release of ADEA claims set forth in this Agreement, or from pursuing claims for workers’ compensation or unemployment benefits referenced in Paragraph No. 5 above, and this Paragraph will not
apply when prohibited by law. If you do not abide by this Paragraph, then: (i) you will return all monies received under this Agreement and indemnify Releasees for all expenses they incur in defending the action; and (ii) Releasees will be
relieved of their obligations hereunder. 
 7. You acknowledge and reaffirm your post-employment obligations under
Section 7 (non-compete) and Section 8 (proprietary information and developments) of the Employment Agreement. You acknowledge your familiarity with all the Company’s marketed products, products in development, and products which
were, as of September 30, 2011, the focus of the Company’s business development projects (“Current Company Products”) and agree that for 

 
purposes of Section 7(non-compete) of the Employment Agreement, the Company is engaged in the business of developing, acquiring, and commercializing prescription respiratory products, NICU
products and PICU products, and products that are promoted primarily to hospital based physicians (the “Business”). The restrictions of that Section 7 prohibit you from competing with the Current Company Products or engaging in the
Business. In addition, you and the Company agree that the requirements in Section 7(b) of the Employment Agreement that you will sever all marketing and sales relationships with customers of the Company and that you will not attempt to retain
those customers for your own or another’s benefit shall not prohibit you from maintaining such relationships so long as you do not use such relationships to compete with the Company. 

8. You will be afforded ten (10) calendar days after the Termination Date to submit to the Company, to the attention of the
Director, Human Resources in the manner set forth in Paragraph No. 20, any and all documentation for any expense reimbursements you claim are owed to you in conjunction with your employment with the Company. You will be reimbursed for any
reasonable business expenses incurred and approved through the Termination Date consistent with Company policy, subject to the submission of the properly documented business expense reports and according to the Company’s normal expense
reimbursement practices and subject to the provisions of Attachment B. 
 9. You are afforded up to twenty-one
(21) calendar days from receipt of this Agreement to consider the meaning and effect of this Agreement and general release and you acknowledge that you have been given twenty-one (21) calendar days to consider it. You are advised to
consult with an attorney regarding this Agreement and you acknowledge that you have had the opportunity to do so. 
 10. You
agree that you will return to the Company by the Termination Date all Company property and equipment in your possession or control, including but not limited to, all documents, tapes, notes, computer files, equipment, company vehicles, physician
lists, employee lists, lab notebooks, files, computer equipment, security badges, telephone calling cards, credit cards, and other information or materials (and all copies) which contain confidential, proprietary or non-public information of the
Company. You further agree to leave intact all electronic Company documents on the Company’s servers or computers, including those which you developed or helped develop during your employment. Notwithstanding the foregoing, you may
keep the cellular telephone that was provided to you by the Company, but all Company confidential, proprietary, and non-public information of the Company must be deleted from that telephone by you promptly after the Termination Date. 

11. Nothing herein limits either party’s right, where applicable, to file or participate in an investigative proceeding of any
federal, state or local governmental agency, provided however, that by signing this Agreement, you waive the right to seek or receive any money damages or other relief of any nature whatsoever from the Company based upon any claim that might be
asserted arising out of your employment at the Company. You further affirm that you have been paid and have received all leave (paid or unpaid), compensation, wages, bonuses, commissions, severance and/or benefits to which you may be entitled and
that no other leave (paid or unpaid), compensation, wages, bonuses, commissions, severance and/or benefits are due to you, except as provided in this Agreement. You furthermore affirm that you have no known workplace injuries or
occupational diseases. You also affirm that you have not been retaliated against for reporting any allegations of wrongdoing by the Company or its officers, including any allegations of corporate fraud. 

 12. This Agreement, which includes a general release, represents the complete agreement
between you and the Company, and fully supersedes any prior agreements or understandings between the parties (including, without limitation, your Employment Agreement, except that your post-employment obligations thereunder shall survive in full
force and effect). You acknowledge that you have not relied on any representations, promises, or agreements of any kind made to you in connection with your decision to sign this Agreement, except those set forth herein. 

13. This Agreement, which shall be construed under the law of the State of North Carolina, shall be binding upon the parties and may not
be abandoned, supplemented, changed or modified in any manner, orally or otherwise, except by an instrument in writing of concurrent or subsequent date signed by a duly authorized representative of the parties hereto. This Agreement is binding
upon and shall inure to the benefit of the parties and their respective agents, assigns, heirs, executors, successors and administrators. The parties hereby consent to jurisdiction in the State of North Carolina for purposes of any litigation
relating to this Agreement and agree that any litigation by or involving them relating to this Agreement shall be conducted in the state or federal courts of the State of North Carolina. 

14. Should any provision of this Agreement be declared or be determined by any court of competent jurisdiction to be illegal or invalid,
the validity of the remaining parts, terms, or provisions shall not be affected thereby and said illegal and invalid part, term or provision shall be deemed not to be a part of this Agreement. The language of all parts of this Agreement shall
in all cases be construed as a whole, according to its fair meaning, and not strictly for or against any of the parties. 
 15.
You understand and agree that as a condition for payment to you of the monetary consideration herein, you shall not make any false, disparaging or derogatory statements in public or private to any person or media outlet regarding the Company or any
of its current, past or future directors, officers, employees, agents, or representatives or the Company’s business affairs and financial condition, except if testifying truthfully under oath pursuant to a lawful court order or
subpoena. If you receive such a court order or subpoena, to the extent allowed by law, you or your attorney shall provide the Company with a copy of such court order or subpoena within two (2) business days of your receipt of it and shall
notify the Company of the content of any testimony or information to be provided and shall provide the Company with copies of all documents to be produced. Similarly, the Company agrees that it will not make, and it will use its best efforts to
assure that its employees do not make, any false, disparaging or derogatory statements in public or private to any person or media outlet regarding you, except if testifying truthfully under oath pursuant to a lawful court order or subpoena.

 16. No delay or admission by the Company in exercising any right under this Agreement shall operate as a waiver of that or
any other right. A waiver or consent given by the Company on any one occasion shall be effective only in that instance and shall not be construed as a bar or waiver of any right on any other occasion. 

 17. You acknowledge and agree that notwithstanding the provisions of Attachment B
(i) neither the Company nor the Company’s legal counsel makes any representation or warranty if any provisions of this Agreement or any payments made pursuant to this Agreement are, or may be determined to constitute, “nonqualified
deferred compensation” within the meaning of Section 409A and (ii) the Company shall have no liability to you or any other person if any payments pursuant to the provisions of this Agreement are determined to constitute nonqualified
deferred compensation subject to Section 409A and do not satisfy the requirements of Section 409A. Notwithstanding any other provision of this Agreement, the Company has the right to and the Company intends to comply with all
withholding and reporting obligations under Section 409A. You are advised to consult with an attorney regarding this Agreement and you acknowledge that you have had the opportunity to do so. 

18. You may revoke this Agreement for a period of seven (7) calendar days following the day you execute this Agreement. Any
revocation within this period must be in writing and must state, “I hereby revoke my acceptance of the Separation Letter Agreement and General Release.” The revocation must be delivered to the following address: 

Cornerstone Therapeutics Inc. 
 Attention: Rhonda P. Downum, Director, Human Resources 
 1255
Crescent Green Drive, Suite 250 
 Cary, North Carolina 27518 

This Agreement shall not become effective or enforceable until the revocation period has expired. 

19. For the convenience of the parties, this Agreement may be executed by facsimile and in counterparts, each of which shall be deemed to
be an original, and both of which taken together, shall constitute one agreement binding on both parties. 
 20. Except as
otherwise provided in this Agreement, all notices required or permitted under this Agreement shall be in writing and shall be deemed effective upon personal delivery or upon the day that is three (3) days after deposit in the United States Post
Office, by registered or certified mail, postage prepaid, addressed to the other party at the address shown below (or at such other address or addresses as either party shall designate to the other in accordance with this Paragraph No. 20):

  

	 	(a)	If to the Company: 

 Cornerstone Therapeutics Inc. 
 Attention: Rhonda P. Downum,
Director, Human Resources 
 1255 Crescent Green Drive, Suite 250 

Cary, North Carolina 27518 
  

	 	(b)	If to the Employee: 

 Steven Lutz 
 123 Trellingwood 

Morrisville, NC 27560 

 21. You agree not to disclose to anyone, either directly or indirectly, any information
whatsoever regarding the existence, terms or contents of this Agreement, except your immediate family, attorneys, financial advisors, accountants, and tax preparation professionals, provided that they agree to keep such information strictly
confidential, until such time as the existence of this Agreement or such terms or contents of this Agreement are disclosed in the Company’s filings with the U.S. Securities and Exchange Commission. This includes, but is not limited to,
present or former employees of the Company and other members of the public. Violation of this Paragraph shall be deemed a material breach of this Agreement. 
 Cornerstone Therapeutics Inc. would like to extend its appreciation to you for your past service, and its sincere hope for success in your future endeavors. 

 

							
		 		 	Very truly yours,
			
		 		 	CORNERSTONE THERAPEUTICS INC.
				
		 		 	 By:
	 	/s/ Craig A. Collard
		 		 	 Name:
	 	Craig A. Collard
		 		 	 Title:
	 	Chief Executive Officer

 ACCEPTED AND AGREED: 
 You have been advised in writing that you have up to twenty-one (21) calendar days from receipt of this Separation Letter Agreement and General Release (this “Agreement”) to consider this
Agreement and you and the Company agreed to extend that period for an additional twenty-one (21) days. You have also been advised to consult with an attorney prior to the execution of this Agreement.

Having elected to execute this Agreement, to fulfill the promises set forth herein, and to receive thereby the sums and benefits set
forth in Paragraph No. 3 of this Agreement, you freely and knowingly, and after due consideration, enter into this Agreement intending to waive, settle, and release all claims you have or might have against Cornerstone Therapeutics
Inc. You have carefully read this Agreement and understand the contents herein. 
  

							
				
	Date: 10-26     , 2011	 		 		 	/s/ Steven M. Lutz
		 		 		 	Name: Steven M. Lutz

 ATTACHMENT A 

DESCRIPTION OF SEVERANCE BENEFITS 
  

	1.	Severance Payments. The Company will pay to you the following lump sum amounts, less lawful deductions: (a) $267,800.00, which equals one year
of your base salary; and (b) $80,340.00, which equals 75% of your full year Target Cash Bonus (as defined in your Employment Agreement) for 2011, with such payments to be made within ten (10) calendar days following the effective date of
the Agreement, provided you execute, timely return, and do not revoke the Separation Letter Agreement and General Release (the “Agreement”) to which this Attachment A is attached. 

 

	2.	Continuation of Benefits. The Company will pay on a monthly basis an amount equal to: 

 

	 	(a)	one hundred percent (100%) of your monthly health, dental and vision COBRA premiums for you and your dependents, if any, if you properly elect to continue health,
dental and vision insurance under COBRA to be paid beginning on the last day of the first payroll-cycle after the expiration of the revocation period provided in Paragraph No. 18 of the Agreement; and 

 

	 	(b)	$148.22 (which represents one hundred percent (100%) of the cost of the monthly premiums paid by the Company for life insurance and disability insurance for you in
the month preceding the end of your employment) to be paid on the first business day of each month after the expiration of the revocation period provided in Paragraph No. 18 of the Agreement; 

such payments under Subsections 2(a) and 2(b) of this Attachment A to continue until the COBRA Contribution End Date (defined for purposes of this
Agreement as the date that is the earlier of (i) twelve (12) months after the Termination Date or (ii) the last day of the first month that you are eligible for other employer-sponsored health coverage). 

 

	3.	Accelerated Vesting of Stock Options. All of your unvested stock options that would have vested at any time before September 30, 2012, shall
immediately vest as of the Termination Date. 

  

	4.	Increased Exercise Period for Stock Options. The period of time over which you may exercise your vested stock options shall be increased such that it
expires on June 30, 2012. 

 ATTACHMENT B 

PAYMENTS SUBJECT TO SECTION 409A 
 Subject to the provisions in this Attachment B, any severance payments or benefits under the Agreement shall begin only upon the date of your “separation from service” (determined as set
forth below) which occurs on or after the date of termination of your employment. The following rules shall apply with respect to distribution of the payments and benefits, if any, to be provided to you under the Agreement: 

 

	1.	If, as of the date of your “separation from service” from the Company, you are a “specified employee” (within the meaning of Section 409A),
then: 

  

	 	a.	Each installment of the severance payments and benefits due under the Agreement that, in accordance with the dates and terms set forth herein, will in all
circumstances, regardless of when the separation from service occurs, be paid within the Short-Term Deferral Period (as hereinafter defined) shall be treated as a short-term deferral within the meaning of Treasury Regulation
Section 1.409A-1(b)(4) to the maximum extent permissible under Section 409A. For purposes of this Agreement, the “Short-Term Deferral Period” means the period ending on the later of the fifteenth day of the third month
following the end of your tax year in which the separation from service occurs and the fifteenth day of the third month following the end of the Company’s tax year in which the separation from service occurs; and 

 

	 	b.	Each installment of the severance payments and benefits due under the Agreement that is not described in paragraph 1(a) above and that would, absent this subsection, be
paid within the six-month period following your “separation from service” from the Company shall not be paid until the date that is six months and one day after such separation from service (or, if earlier, your death), with any such
installments that are required to be delayed being accumulated during the six-month period and paid in a lump sum on the date that is six months and one day following your separation from service and any subsequent installments, if any, being paid
in accordance with the dates and terms set forth herein; provided, however, that the preceding provisions of this sentence shall not apply to any installment of severance payments and benefits if and to the maximum extent that that
such installment is deemed to be paid under a separation pay plan that does not provide for a deferral of compensation by reason of the application of Treasury Regulation 1.409A-1(b)(9)(iii) (relating to separation pay upon an involuntary
separation from service) or such payments or benefits are otherwise exempt from Section 409A. Any installments that qualify for the exception under Treasury Regulation Section 1.409A-1(b)(9)(iii) must be paid no later than the last
day of your second taxable year following your taxable year in which the separation from service occurs. 

	2.	The determination of whether and when your separation from service from the Company has occurred shall be made and in a manner consistent with, and based on the
presumptions set forth in, Treasury Regulation Section 1.409A-1(h). Solely for purposes of this paragraph 2, “Company” shall include all persons with whom the Company would be considered a single employer under
Section 414(b) and 414(c) of the Code. 

  

	3.	All reimbursements and in-kind benefits provided under the Agreement shall be made or provided in accordance with the requirements of Section 409A to the extent
that such reimbursements or in-kind benefits are subject to Section 409A, including, where applicable, the requirement that (i) any reimbursement is for expenses incurred during Employee’s lifetime (or during a shorter period of time
specified in this Agreement), (ii) the amount of expenses eligible for reimbursement during a calendar year may not affect the expenses eligible for reimbursement in any other calendar year, (iii) the reimbursement of an eligible expense
will be made on or before the last day of the calendar year following the year in which the expense is incurred and (iv) the right to reimbursement is not subject to set off or liquidation or exchange for any other benefit.2012 Management Incentive Plan

 Exhibit 10.1 
 2012 Management Incentive Plan 
 The 2012 Management Incentive Plan (the “Plan”)
applies to employees of Accelrys for achievement of Objectives as defined in this Plan. The Plan is designed to support the growth and profitability of the organization. 
 Definitions 
  

			
		
	The Plan:	  	The 2012 Management Incentive Plan.
		
	The Company:	  	Refers to Accelrys Inc. and its affiliates.
		
	Plan Participant:	  	A regular employee of the Company in the following levels: CEO, Vice President, Director and eligible members of the Marketing organization who are not already participating in
an alternative commission or incentive plan and are employed by the Company through the completion of 2012.
		
	Orders:	  	The aggregate value of orders (as defined by the Company in its orders policy) as determined and achieved for the calendar year ending December 31, 2012.
		
	Non-GAAP Operating Income	  	Total non-GAAP operating income achieved by the Company in the calendar year ending December 31, 2012 as disclosed in the Company’s SEC filings.

 Eligibility & Applicability 
 To be eligible for participation in the Plan, a Plan Participant must be employed by the Company prior to and through the completion of the calendar year. 

Plan participants who are partial year employees must be employed by the Company prior to and through the completion of the calendar year in order to
receive a pro-rated payment under the Plan. 
 Term 
 This Plan is effective for the calendar year ending December 31, 2012. 
 Plan Structure

 Each Plan Participant is eligible to earn a target incentive equal to his/her annual bonus target percentage multiplied by his/her annual
base salary. 
 Earnings under the Plan result from successful performance against a combination of two Financial Metrics (Orders and Non-GAAP
Operating Income Targets) and against Individual Performance Objectives. 
 The two Financial Metrics of the Plan are equally weighted and
specific participation in the Plan is in accordance with the following: 
 Executive Officer-level Participants: funding achievement
under the Plan is tied to the two Financial Metrics (non-GAAP Operating Income and Orders Target) upon which 80% of target bonus is earned. The remaining 20% of target bonus is subject to individual performance objectives and may be awarded at the
sole discretion of Accelrys’ CEO. Such participants may achieve up to 200% of target incentive. In keeping with the nature of her role, the target incentive for the Senior Vice President of Global Sales and Services shall be weighed more
heavily toward the Orders Target. 
 All Other Plan Participants: In general, most Vice President-level participants may earn 80% of
their target bonus upon achievement of the Financial Metrics listed above, with the remainder their target bonus subject to individual performance objectives. Most Other Plan Participants may earn 50% of their target bonus based upon achievement of
the two Financial Metrics (non-GAAP Operating Income and Orders Target) with the remaining 50% of their target bonus subject to individual performance objectives which may be awarded at the sole discretion of Accelrys’ CEO. 

Payment Schedule 
 Incentives shall be
earned for the applicable fiscal year and shall be paid in the quarter that follows the year for which the incentive is earned. 
 General
Provisions 
 A Plan Participant shall not assign nor give any part of an incentive to any agent, customer or representative of the customer,
or any other person, as an inducement in obtaining an order. Unless expressly approved in advance by the CEO of the Company, a Plan Participant shall not accept any compensation from third parties related to sales of third party products or services
made by the Company. 
 In the event that any Plan Participant compensated in accordance with this Plan owes any sum of money to the Company,
including without limitation draw payments, charge backs, and travel advances, the Company shall have the right at any time to offset such obligations against the employee’s base salary, commissions, or bonuses. 

The Company reserves the right without advance notice to: 
  

	 	1.	Accept, reject, or cancel any order; 

  

	 	2.	Make any adjustments or revisions to incentive rates, quotas, salaries, or any other matters pertaining to this Plan; and 

 

	 	3.	Resolve, in its sole and absolute discretion, any matters of interpretation under the Plan and matters not covered by the provisions of the Plan.

  

	 	4.	Modify or terminate this Plan at any time. 

 The contents of this Plan are Company Proprietary and Confidential, and are not to be disclosed by any Plan
Participant to any person who is not an employee of the Company. Any legal action brought concerning this Plan shall be brought only in the state or federal courts of the country in which the Plan Participant is employed and both parties submit to
venue and jurisdiction in these courts. This Plan contains the entire agreement of the parties with respect to the matters addressed herein, and supersedes all other representations, statements and understandings concerning this subject matter.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00200-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00200-of-00352.parquet"}]]